SI-BONE Inc. Common Stock
(NASDAQ:SIBN)
Description
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Overview
None
Sector |
Health Care |
Industry |
Medical/Dental Instruments |
Previous Close |
$24.8100 |
Previous Close Volume |
205490 |